Chronic pancreatitis correlates with increased risk of herpes zoster in a population‐based retrospective cohort study

Lai, Shih‐Wei; Lin, Cheng‐Li; Liao, Kuan‐Fu

doi:10.1002/jhbp.575

Cited by 13 publications

(8 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Weitere gesundheitlichen Risiken sind bei CP-Patienten beschrieben: erhöhtes Risiko für das Auftreten einer Urolithiasis, einer entzündlichen Darmerkrankung, von tiefen Beinvenenthrombosen und Lungenembolien, Lungenkarzinom und Herpes zoster. Diese Komorbiditäten begünstigen eine erhöhte Langzeit-Letalität 351 644 645 646 647 648 649 650 651 652 653 654 655 656 657 .…”

Section: üBerwachung Und Verlaufskontrolleunclassified

S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – September 2021 – AWMF Registernummer 021-003

et al. 2022

View full text Add to dashboard Cite

Kapitel: Definition und Ätiologie der akuten Pankreatitis 427 2. Schweregradeinschätzung einer akuten Pankreatitis 431 3. Bildgebung bei akuter Pankreatitis 435 4. Volumen-und Schmerztherapie, Intensivmedizinische Therapie bei akuter Pankreatitis 438 5. Antibiotika, Probiotika und Ernährung bei akuter Pankreatitis (Prävention und Therapie infektiöser Komplikationen) 442 6. Akute biliäre Pankreatitis und Therapie biliärer Komplikationen 445 7. Indikation, Zeitpunkt und Therapieverfahren bei infizierter Nekrose 448 8. Verlaufskontrolle nach akuter Pankreatitis 452 9. Definition, Epidemiologie und Ätiologie der chronischen Pankreatitis 456 9.1. Definition 456 10. Diagnostik (Funktionstests, Bildgebung, Klassifikation) bei chronischer Pankreatitis 459 10.3. Funktionstests 459 10.4. Bildgebung 461 10.5. Klassifikation 462 11. Medikamentöse Therapie der chronischen Pankreatitis 464 11.1. Akuter Schub 464 11.2. Schmerztherapie 464 11.3. Enzymsubstitution bei chronischer Pankreatitis 467 11.4. Ernährung 470 Inhaltsverzeichnis Seite 12. Endoskopische und interventionelle Therapie 471 12.1. Indikationsstellung 471 12.2. Therapie von Pseudozysten 473 12.3. Therapie von Pseudoaneurysmen 476 12.4. Therapie von Pankreasgangveränderungen und Pankreasgangsteinen bei chronischer Pankreatitis 477 12.5. Endoskopische Therapie von Gallengangsstenosen bei chronischer Pankreatitis 479 13. Indikationsstellung und chirurgische Therapie bei chronischer Pankreatitis 480 14. Überwachung und Verlaufskontrolle 484 15. Diagnostik und Therapie der chronischen Pankreatitis im Kindesalter 486 15.2. Klinisches Bild der Pankreatitis bei Kindern und Jugendlichen 486 15.3. Ätiologie und Häufigkeitsverteilung der Pankreatitis im Kindes-und Jugendalter 486 15.4. Komplikationen der Pankreatitis bei Kindern und Jugendlichen 487 15.5. Labordiagnostik bei V. a. Pankreatitis im Kindesund Jugendalter 487 15.6. Bildgebende Diagnostik bei Pankreatitis im Kindes-und Jugendalter 488 15.7. Genetische Diagnostik bei Pankreatitis im Kindes-und Jugendalter 489 15.8. Spezifische Diagnostik zum Ausschluss einer zystischen Fibrose bei Kindern und Jugendlichen mit chronischer Pankreatitis 489 15.9. Supportive Therapiemaßnahmen bei Kindern und Jugendlichen im akuten Schub einer Pankreatitis 490 15.10. Endoskopisch-interventionelle Therapie bei Kindern und Jugendlichen mit Pankreatitis 490 15.11. Operative Therapie bei Kindern und Jugendlichen mit Pankreatitis 490 15.12. Schmerztherapie der chronischen Pankreatitis bei Kindern und Jugendlichen 490 15.13. Ernährung bei Kindern im akuten Schub einer Pankreatitis 491

show abstract

Section: üBerwachung Und Verlaufskontrolleunclassified

S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – September 2021 – AWMF Registernummer 021-003

et al. 2022

View full text Add to dashboard Cite

show abstract

“…1 The cause of herpes zoster results from a reactivation of latent varicella-zoster virus dormant in dorsal root ganglia. 2 This type of reactivation usually results from declined host immunity associated with a wide variety of conditions, including various autoimmune diseases, asthma, chronic obstructive pulmonary disease (COPD), chronic pancreatitis (CP), diabetes mellitus (DM) and advancing age, 3,4 but the association of cirrhosis has not yet been clarified.…”

Section: Introductionmentioning

confidence: 99%

Association between cirrhosis and herpes zoster in a cohort study in Taiwan

et al. 2021

View full text Add to dashboard Cite

Objectives The aim of the study was to assess if an association exists between cirrhosis and herpes zoster in Taiwan. Methods A retrospective cohort study was designed to analyse the 2000‐2013 claim dataset of 1 million insured residents who were randomly sampled from the Taiwan National Health Insurance Program. In total, 16 190 subjects aged 20‐84 years old with newly diagnosed cirrhosis since 2000 to 2012 were identified as the cirrhosis group and 16 190 sex‐ and age‐matched subjects without cirrhosis were selected as the non‐cirrhosis group. Both cirrhosis and non‐cirrhosis groups were followed until a new diagnosis of herpes zoster was made or until the end of 2013. The multivariable Cox proportional hazard regression model was applied to calculate the hazard ratio (HR) and 95% confidence interval (CI) for herpes zoster associated with cirrhosis. Results The incidence rate of herpes zoster was 1.08‐fold greater in the cirrhosis group than the non‐cirrhosis group (8.33 vs 7.69 per 1000 person‐years, 95%CI 1.02‐1.15). After adjusting for confounders, the adjusted HR of herpes zoster was 1.11 (95% CI 1.004‐1.24) for the cirrhosis group compared with the non‐cirrhosis group. The adjusted HR increased to 1.33 (95% CI 1.02‐1.74) for the decompensated cirrhosis group compared with the non‐cirrhosis group. Conclusions Cirrhosis is associated with a small but significant increase in the risk of herpes zoster. Given that the risk of herpes zoster is small and the expense of herpes zoster vaccination is high, whether cirrhotic persons need to be vaccinated should assess the balance of cost and benefit.

show abstract

“…Herpes zoster and postherpetic neuralgia create a significant health concern because of the declined life quality of an affected person and the economic burden on healthcare systems 4 . A number of well‐established risk factors and comorbidities are found to be associated with impaired cell‐mediated immunity, including older age, malignancy, immunosuppressive status, diabetes mellitus, inflammatory bowel disease, and chronic pancreatitis 5–7 . These factors and comorbidities predispose some individuals at greater risk of developing herpes zoster.…”

Section: Introductionmentioning

confidence: 99%

“…4 A number of well-established risk factors and comorbidities are found to be associated with impaired cell-mediated immunity, including older age, malignancy, immunosuppressive status, diabetes mellitus, inflammatory bowel disease, and chronic pancreatitis. [5][6][7] These factors and comorbidities predispose some individuals at greater risk of developing herpes zoster. In addition, meteorological conditions, such as seasonal variation and ambient temperature variation, were found to be associated with the reactivation of the latent varicella-zoster virus and also predispose the host at greater risk of developing herpes zoster.…”

Section: Introductionmentioning

confidence: 99%

The impacts of ambient temperature and ultraviolet radiation on the incidence of herpes zoster: An ecological study in Taiwan

Lai

Liao

Kuo³

et al. 2020

Int J Clin Pract

View full text Add to dashboard Cite

The aim of the study was to examine the relationship between ambient temperature, ultraviolet radiation, and the development of herpes zoster in Taiwan. An ecological study was conducted to analyse the database of the Taiwan National Health Insurance Programme. Participants aged ≥20 years with newly diagnosed herpes zoster between 2003 and 2012 were selected for analysis. The monthly incidence rate of herpes zoster was measured between 2003 and 2012. Monthly average ambient temperature in Celsius (°C) between 2003 and 2012 was measured according to the official database of the Central Weather Bureau in Taiwan. Monthly accumulated ultraviolet radiation (MJ m−2) between 2003 and 2012 was measured according to the official database of the Environmental Protection Administration in Taiwan. The overall incidence rates of herpes zoster ranged from 2.54 to 5.67 per 10 000 persons per month from 2003 to 2012.The monthly average ambient temperature was higher and the monthly accumulated ultraviolet radiation was stronger from May to October. The incidence rates of herpes zoster seemed to be high during the period of high ambient temperature and strong ultraviolet radiation (from May to October).Whenever ambient temperature increased 1°C per month, the incidence rate of herpes zoster increased by 0.072 per 10,000 persons per month. Whenever ultraviolet radiation increased 1 MJ m−2 per month, the incidence rate of herpes zoster increased by 0.313 per 10 000 persons per month. There is a significant association between ambient temperature, ultraviolet radiation, and the development of herpes zoster in Taiwan. The incidence rate of herpes zoster is high during the period of high ambient temperature and strong ultraviolet radiation. Low ambient temperature and weak ultraviolet radiation might be beneficial for the prevention of herpes zoster.

show abstract

Chronic pancreatitis correlates with increased risk of herpes zoster in a population‐based retrospective cohort study

Abstract: Chronic pancreatitis correlates with 1.35-fold increased risk of herpes zoster. From a view of primary prevention, we suggest that patients with chronic pancreatitis should receive herpes zoster vaccination.

Cited by 13 publications

References 33 publications

S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – September 2021 – AWMF Registernummer 021-003

S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – September 2021 – AWMF Registernummer 021-003

Association between cirrhosis and herpes zoster in a cohort study in Taiwan

The impacts of ambient temperature and ultraviolet radiation on the incidence of herpes zoster: An ecological study in Taiwan

Contact Info

Product

Resources

About